Chinese consumers bought US$176.1 billion worth of goods online in the first half of 2014, almost 10% of all retail sales. Great potential, admits financial analyst Sara Hsu in The Diplomat, although there are also major barriers for its development.Read More →

Innovation and China have not been an obvious combination of the past few decades. US vice-president Joe Biden even challenged us to name any innovation from China. Business analyst Shaun Rein takes Biden on in his upcoming book The End of Copycat China: The Rise of Creativity, Innovation, and Individualism in Asia.Read More →

Anti-trust actions, anti-corruption drives and safety issues have made corporate life for foreign firms in China tougher than 10, 15 years ago. Whether they will actually leave China in larger numbers depends on how the costs of doing business develop, writes financial analyst Sara Hsu in the Diplomat.Read More →

Six years after introducing anti-trust legislation, China´s authorities have started to use those tools. Foreign firms fear they are targets, but business analyst Ben Cavender sees at CNBC another reason: the growing anxiety at the central government for the huge inequality in China´s incomes.Read More →

China´s central government tries to shift its economy from investment-driven to a consumer-drive one. While the effort seems to have effect, financial analyst Sara Hsu points at a few bears at this road in the Diplomat. Will the consumers keep on spending more? It´s in the hand of the government itself.Read More →

Has China become an imperial force in Africa? Author Howard French of China’s Second Continent: How a Million Migrants Are Building a New Empire in Africa discusses the question how China jumped into a power vacuum in Africa and took the opportunities left by others. The use of the word “empire” has triggered off a debate, and French explains at ChinaFile how he sees Sino-African relations.Read More →

Expiring drug patents, including those of Pfizer´s Viagra, is not going to change the market in China, says retail analyst Ben Cavender at CNBC. Most of those drugs are anyway already available in China, he says. And the second-child hype most more materialize.Read More →

China´s is setting up five asset management companies or bad banks to buy up bad debts on a local level, comparable to five national firms that bailed out China´s largest banks in the 1990s. But that will not help, if the current fiscal dilemmas for local governments are not solved, writes financial analyst Sara Hsu in the Diplomat.Read More →